scholarly article | Q13442814 |
P50 | author | Colin B Ligon | Q57323447 |
P2093 | author name string | Lydia Gedmintas | |
Marisa Tungsiripat | |||
Leonard Calabrese | |||
Sintawat Wangsiricharoen | |||
Clifton Bingham | |||
Carlos Lozada | |||
Admad Dehrab | |||
P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
The rising challenge of non-AIDS-defining cancers in HIV-infected patients | Q26861496 | ||
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries | Q34216770 | ||
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma | Q35511780 | ||
Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease | Q36330070 | ||
Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report | Q36826300 | ||
Liver and kidney transplantation in HIV-infected patients. | Q37639166 | ||
Use of tumor necrosis factor (TNF) inhibitors in patients with HIV/AIDS. | Q38698940 | ||
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis | Q38882228 | ||
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1. | Q40936133 | ||
Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis | Q44877235 | ||
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes | Q46757223 | ||
Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2 | Q74343625 | ||
The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease | Q80197399 | ||
Pulmonary and nodal tuberculosis in a patient with inflammatory bowel disease and HIV infection treated with infliximab | Q82963639 | ||
P433 | issue | 3 | |
P304 | page(s) | 449-452 | |
P577 | publication date | 2017-03-01 | |
P1433 | published in | Arthritis Care and Research | Q15754720 |
P1476 | title | Rates of Serious Infections in HIV-Infected Patients Receiving Tumor Necrosis Factor Inhibitor Therapy for Concomitant Autoimmune Diseases | |
P478 | volume | 69 |